Kyverna Therapeutics, Inc. KYTX Non Cash Interest Expense
Non Cash Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept kytx:NonCashInterestExpense.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s non cash interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s non cash interest expense?
- Kyverna Therapeutics, Inc. (KYTX) reported non cash interest expense of $114K in Q1 2026.
- What does non cash interest expense mean?
- This reflects interest-related expenses that are recognized in the income statement but do not result in a cash outflow during the period, such as the amortization of debt issuance costs or original issue discounts. It is added back to net income to reconcile to operating cash flow. This metric helps distinguish between the company's actual cash interest burden and its total accounting interest expense.